Showing results (101-110 of 1,707) with videos related to

Sort By:
Pageof 171
Human Vaccines|April 30, 2008
Immunogenicity of DNA vaccines in humans: it takes two to tangoShan Lu
Emerging Microbes & Infections|June 4, 2015
Using convalescent whole blood or plasma as passive immune therapy for the global war against EbolaShan Lu
Molecular Cancer Therapeutics|July 11, 2007
A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cellsShan Lu, Amy Wang, Shan Lu, et al.
Virology|March 8, 2005
Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)Te-hui W Chou, Shixia Wang, Pavlo V Sakhatskyy, et al.
Human Vaccines & Immunotherapeutics|September 22, 2017
Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccinesShixia Wang, Te-Hui Chou, Anthony Hackett, et al.
Vaccine|October 13, 2005
Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbitsRanajit Pal, Qiao Yu, Shixia Wang, et al.
Cancer Letters|August 3, 2010
Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamideShan Lu, Zongqin Tan, Matthew Wortman, et al.
International Journal of Oncology|January 1, 2010
Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cellsShan Lu, Zongqin Tan, Matt Wortman, et al.
Virology|April 18, 2006
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and EShixia Wang, Ranajit Pal, John R Mascola, et al.
Vaccine|February 5, 2008
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteersShixia Wang, Jeffrey S Kennedy, Kim West, et al.
Pageof 171